|
Q4 FY2023
As of Jan 31, 2023
|
Q3 FY2023
As of Oct 31, 2022
|
Q2 FY2023
As of Jul 31, 2022
|
Q1 FY2023
As of Apr 30, 2022
|
Q4 FY2022
As of Jan 31, 2022
|
Q3 FY2022
As of Oct 31, 2021
|
Q2 FY2022
As of Jul 31, 2021
|
Q1 FY2022
As of Apr 30, 2021
|
Q4 FY2021
As of Jan 31, 2021
|
Q3 FY2021
As of Oct 31, 2020
|
|
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets: | ||||||||||
| Cash and cash equivalents | ||||||||||
| Marketable securities, current | ||||||||||
| Accounts receivable, net | ||||||||||
| Prepaid expenses | ||||||||||
| Deferred sales commissions, current | ||||||||||
| Other current assets | ||||||||||
| Total current assets | ||||||||||
| Marketable securities, noncurrent | ||||||||||
| Property and equipment, net | ||||||||||
| Operating lease right-of-use assets | ||||||||||
| Goodwill | ||||||||||
| Acquired intangible assets, net | ||||||||||
| Deferred sales commissions, noncurrent | ||||||||||
| Other assets | ||||||||||
| Total assets | ||||||||||
| Liabilities and stockholders’ equity | ||||||||||
| Current liabilities: | ||||||||||
| Accounts payable | ||||||||||
| Accrued expenses and other current liabilities | ||||||||||
| Operating lease liabilities, current | ||||||||||
| Deferred revenue, current | ||||||||||
| Total current liabilities | ||||||||||
| Operating lease liabilities, noncurrent | ||||||||||
| Deferred revenue, noncurrent | ||||||||||
| Redeemable convertible preferred stock warrant liability | ||||||||||
| Other liabilities | ||||||||||
| Total liabilities | ||||||||||
| Redeemable convertible preferred stock $0.0001 par value— 100,000 shares and 65,091 shares authorized as of January 31, 2021 and 2020, respectively; no shares and 63,762 shares issued and outstanding (liquidation preference $344,542) as of January 31, 2021 and 2020, respectively | ||||||||||
| Stockholders’ equity: | ||||||||||
| Common stock $0.0001 par value— 1,000,000 shares authorized as of January 31, 2023 and 2022; 122,388 and 113,813 shares issued and outstanding as of January 31, 2023 and 2022, respectively | ||||||||||
| Additional paid-in-capital | ||||||||||
| Accumulated other comprehensive loss | ||||||||||
| Accumulated deficit | ||||||||||
| Total stockholders’ equity | ||||||||||
| Total liabilities and stockholders’ equity | ||||||||||
| Redeemable convertible preferred stock, shares authorized (in shares) | ||||||||||
| Common stock, shares authorized (in shares) |
Loading...